Menu

Annina Schmid Dissects Nerve Disorders

A background in physiotherapy helps the Oxford-based researcher mix basic science with clinical work to better understand pain stemming from nerve compression.

Jan 1, 2018
Catherine Offord

© JOHN CAIRNS

As a physiotherapist at University Hospital Zurich in the mid-2000s, Annina Schmid often encountered people with chronic pain. “My interest in research got sparked while I was seeing my patients,” she says. “It was very difficult to treat them, or to understand why pain persists in some people, while it doesn’t even occur in others.”

Schmid, who grew up in Switzerland, had earned her master’s degree in clinical physiotherapy in 2005 at Curtin University in Perth, Australia, and she was keen to return down under. In 2008, she secured an Endeavour Europe Scholarship from the Australian Government and moved to the University of Queensland in Brisbane for a PhD in neuroscience.

“She’s very motivated,” says Schmid’s colleague and collaborator Brigitte Tampin, a musculoskeletal physiotherapist at Curtin University and at Osnabrück University of Applied Sciences in Germany. Tampin adds that Schmid’s physiotherapy background was an asset for her PhD work and beyond. “She can think as a clinician and as a researcher.”

For her PhD, Schmid focused on animal models of mild nerve compression, also called entrapment neuropathy, in which pressure on nerve fibers—from bone, for example—can cause pain and loss of motor function. Using a tube to compress the sciatic nerves of rats, Schmid was able to replicate not only local symptoms seen in humans, but also inflammation at distant sites, a possible explanation for why patients often report pain in other parts of the body.1

By the time she earned her doctorate in 2011, Schmid says she was “hooked” on research. During a subsequent internship with Claudia Sommer at the University of Würzburg, Germany, Schmid processed skin biopsies from patients with the pain syndrome fibromyalgia, and found degeneration in small nerve fibers—a finding she says helped shape her future focus.2

Shortly afterward, Schmid began a postdoc with neurobiologist David Bennett at the University of Oxford’s Nuffield Department of Clinical Neurosciences (NDCN). “She’s always been a joy to work with,” says Bennett. “She’s got a nice way of thinking about interesting and important questions in neuropathic pain.”

Working on patients with carpal tunnel syndrome—a common entrapment neuropathy affecting the wrist—Schmid described reductions in small fiber density and showed that changes in nerve structure occurred even far away from the site of compression.3

In 2015, Schmid won an early career research grant from the International Association for the Study of Pain. Now an associate professor at NDCN, she continues to collaborate with Bennett to study nerve regeneration following compression. She also practices physiotherapy part-time and shares her expertise with students. “Her teaching is always very well received,” says Bennett. “She’s a very good communicator.”

Beyond the University of Oxford, Schmid teaches at Oxford Brookes University and leads international courses for physiotherapists with Tampin. “I’m quite passionate about trying to translate findings from research to clinicians,” Schmid says. “Physiotherapy is a profession that’s still very close to my heart.” 

REFERENCES

  1. A.B. Schmid et al., “Local and remote immune-mediated inflammation after mild peripheral nerve compression in rats,” J Neuropathol Exp Neurol, 72:662-80, 2013. (Cited 32 times)
  2. N. Üçeyler et al., “Small fibre pathology in patients with fibromyalgia syndrome,” Brain, 136:1857-67, 2013. (Cited 210 times)
  3. A.B. Schmid et al., “The relationship of nerve fibre pathology to sensory function in entrapment neuropathy,” Brain, 137:3186-99, 2014. (Cited 23 times)

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!